NO814372L - Analogifremgangsmaate for fremstilling av antibakterielle cefalosporinderivater - Google Patents

Analogifremgangsmaate for fremstilling av antibakterielle cefalosporinderivater

Info

Publication number
NO814372L
NO814372L NO814372A NO814372A NO814372L NO 814372 L NO814372 L NO 814372L NO 814372 A NO814372 A NO 814372A NO 814372 A NO814372 A NO 814372A NO 814372 L NO814372 L NO 814372L
Authority
NO
Norway
Prior art keywords
radical
alkyl
radicals
amino
formula
Prior art date
Application number
NO814372A
Other languages
English (en)
Norwegian (no)
Inventor
Frederic Henri Jung
Gareth Morse Davies
Original Assignee
Ici Pharma
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Pharma, Ici Plc filed Critical Ici Pharma
Publication of NO814372L publication Critical patent/NO814372L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D463/00Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16Nitrogen atoms
    • C07D463/18Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D463/00Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16Nitrogen atoms
    • C07D463/18Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D505/00Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
NO814372A 1980-12-22 1981-12-21 Analogifremgangsmaate for fremstilling av antibakterielle cefalosporinderivater NO814372L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8027254A FR2496666A1 (fr) 1980-12-22 1980-12-22 Nouveaux derives de cephalosporine et composition pharmaceutique les contenant

Publications (1)

Publication Number Publication Date
NO814372L true NO814372L (no) 1982-06-23

Family

ID=9249365

Family Applications (1)

Application Number Title Priority Date Filing Date
NO814372A NO814372L (no) 1980-12-22 1981-12-21 Analogifremgangsmaate for fremstilling av antibakterielle cefalosporinderivater

Country Status (15)

Country Link
US (1) US4492692A (el)
EP (1) EP0055562B1 (el)
JP (1) JPS57167991A (el)
AU (1) AU7878681A (el)
DE (1) DE3173789D1 (el)
DK (1) DK572581A (el)
ES (2) ES8304140A1 (el)
FI (1) FI814132L (el)
FR (1) FR2496666A1 (el)
GR (1) GR76914B (el)
IL (1) IL64512A0 (el)
NO (1) NO814372L (el)
PT (1) PT74173B (el)
YU (2) YU303981A (el)
ZA (1) ZA818594B (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0071370A3 (en) * 1981-07-23 1984-05-16 Ici Pharma Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them
US4504478A (en) * 1981-09-18 1985-03-12 Imperial Chemical Industries Plc Cephalosporin-1-oxide derivatives
EP0082648A3 (en) * 1981-12-21 1984-09-26 Imperial Chemical Industries Plc Cephalosporin derivatives
DK163000C (da) * 1982-09-30 1992-06-01 Shionogi & Co Analogifremgangsmaade til fremstilling af vinylthioacetamido-1-dethia-1-oxa-cephalosporinderivater
JPS59110695A (ja) * 1982-12-16 1984-06-26 Asahi Chem Ind Co Ltd 経口用セフアロスポリン
US4855420A (en) * 1983-06-03 1989-08-08 Ici Pharma Cephalosporin derivatives
US4547573A (en) * 1983-12-02 1985-10-15 Ici Pharma Process for preparing cephalosporin derivatives
US5817823A (en) * 1997-04-17 1998-10-06 Sepracor Inc. Method for synthesizing 2-substituted imidazoles

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1032533A (en) * 1973-09-07 1978-06-06 William H. Koster Process for the production of cephalosporin compounds
JPS55133355A (en) * 1979-04-03 1980-10-17 Shionogi & Co Ltd Inversion of 3-amino group of beta-lactam ring
DE3071707D1 (en) * 1979-04-27 1986-09-25 Merck & Co Inc 7-n-heterocyclyl cephalosporins, a process for preparing and a pharmaceutical composition comprising the same
US4358447A (en) * 1979-04-27 1982-11-09 Merck & Co., Inc. 7-N-Heterocyclyl cephalosporins
FR2472574A1 (fr) * 1979-12-24 1981-07-03 Ici Pharma Derives de cephalosporine et composition pharmaceutique les contenant

Also Published As

Publication number Publication date
DE3173789D1 (en) 1986-03-27
AU7878681A (en) 1982-07-01
PT74173A (en) 1982-01-01
ES508280A0 (es) 1983-02-16
FI814132L (fi) 1982-06-23
YU45886B (sh) 1992-09-07
ES517824A0 (es) 1983-08-16
DK572581A (da) 1982-06-23
US4492692A (en) 1985-01-08
ZA818594B (en) 1982-12-29
FR2496666A1 (fr) 1982-06-25
EP0055562A3 (en) 1982-08-11
GR76914B (el) 1984-09-04
YU110983A (en) 1983-12-31
ES8307818A1 (es) 1983-08-16
YU303981A (en) 1983-12-31
IL64512A0 (en) 1982-03-31
JPS57167991A (en) 1982-10-16
EP0055562B1 (en) 1986-02-12
ES8304140A1 (es) 1983-02-16
EP0055562A2 (en) 1982-07-07
PT74173B (en) 1983-05-17

Similar Documents

Publication Publication Date Title
JPH03135973A (ja) アミノチアゾリル酢酸類
EP0031708B1 (en) Cephalosporin derivatives, processes for their manufacture, pharmaceutical compositions containing them and intermediates therefor
NO164301B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefalosporinderivater.
SE438855B (sv) 3-hydroxikrotonsyraderivat till anvendning sasom mellanprodukt vid syntesen av 3-cefemforeningar
SE450384B (sv) Nya cefemforeningar och forfarande for deras framstellning
JPS61143390A (ja) 化合物
EP0009008A2 (de) Cephalosporinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
SE445644B (sv) 7beta-amino-3-cefem-3-amino-4-karbonsyra-foreningar som mellanprodukter for framstellning av 7beta-amino-3-cefem-3-ol-4-karbonsyra-foreningar
CS199714B2 (en) Process for preparing heteromonocyclic and heterobicyclic derivatives of unsaturated 7-acylamido-3-cephem-4-carboxylic acids
EP0293771A2 (en) Cephalosporin compound and pharmaceutical composition thereof
NO814372L (no) Analogifremgangsmaate for fremstilling av antibakterielle cefalosporinderivater
CA1146535A (en) Aminothiazoles with terminal aminocarboxylic acid grouping
JPS60109590A (ja) 新規セフエム化合物およびその製造方法
US4547573A (en) Process for preparing cephalosporin derivatives
US4497949A (en) Process for the manufacture of cephalosporin derivatives
US4504478A (en) Cephalosporin-1-oxide derivatives
DK159155B (da) Fremgangsmaade til fremstilling af 3-karbamoyloxymetylcephalosporinforbindelser
CA1203235A (en) Process for the manufacture of cephalosporins
EP0082648A2 (en) Cephalosporin derivatives
US4486426A (en) Unsaturated cephalosporin derivatives
EP0018155A2 (en) Novel cephalosporin compounds, a process for the preparation thereof, pharmaceutical compositions containing the same and the use thereof as a therapeutic agent against a microorganism
JPS6117589A (ja) 新規セフアロスポリン誘導体及びその製造法
CH626091A5 (en) Process for preparing enol derivatives
DK145302B (da) Cephalosporansyrederivater til anvendelse som mellemprodukter
NO841268L (no) 7-beta-acylamido-3-cefem-4-karboksylsyreforbindelser, fremgangsmaate til deres fremstilling, farmasoeytiske preparater som inneholder disse forbindelser samt deres anvendelse